C4 Therapeutics (CCCC) FCF Margin Growth (1y) (2020 - 2026)
C4 Therapeutics (CCCC) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
C4 Therapeutics |
492.32 Mn |
256.65 Mn |
- |
-2,749.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,749.00 |
| Dec 31, 2025 |
14,518.00 |
| Sep 30, 2025 |
-12,237.00 |
| Jun 30, 2025 |
-14,957.00 |
| Mar 31, 2025 |
13,632.00 |
| Dec 31, 2024 |
34,294.00 |
| Sep 30, 2024 |
13,112.00 |
| Jun 30, 2024 |
67,258.00 |
| Mar 31, 2024 |
29,025.00 |
| Dec 31, 2023 |
29,696.00 |
| Sep 30, 2023 |
9,866.00 |
| Jun 30, 2023 |
-53,128.00 |
| Mar 31, 2023 |
-53,671.00 |
| Dec 31, 2022 |
-85,780.00 |
| Sep 30, 2022 |
-17,202.00 |
| Jun 30, 2022 |
886.00 |
| Mar 31, 2022 |
-829.00 |
| Dec 31, 2021 |
14,070.00 |
| Sep 30, 2021 |
-4,632.00 |
| Jun 30, 2021 |
-4,012.00 |
